NCT06752304 A Longitudinal Study of Severe and Enduring Eating Disorders
| NCT ID | NCT06752304 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uppsala University Hospital |
| Condition | Eating Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2024-09-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational longitudinal study is to investigate characteristics and factors associated with the development of Severe and Enduring Eating Disorders (SEED). In this project, the researchers will follow two prospective cohorts of patients with eating disorders (ED), one adolescent (ages 14-17) and one adult (ages 18+), in terms of change in and impact of clinical, psychological, and biological risk factors. Data will be collected at baseline, after treatment, two years after baseline, and thereafter five, 10 and 20 years after baseline. Participants will be asked to undergo a physical examination, leave blood samples, be interviewed, and fill in questionnaires. If the participants are minors, their care takers will also fill in the questionnaires. The study aims to explore how clinical, psychological, and biological risk factors-including comorbidity, personality characteristics, difficulties with emotion regulation (ER), cognitive inflexibility, loneliness, severe ED symptoms, and inflammatory activation-contribute to a chronic course of the disorder.
Eligibility Criteria
Inclusion criteria: * found to meet the criteria for an eating disorder * being in need of treatment * having provided written informed consent (for minors, this includes consent from all caregivers and the minors themselves). Exclusion criteria: * Eating disorders symptoms in need of emergency care * High risk for suicide * An inability to respond to the questionnaires due to e.g., lack of knowledge in Swedish.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06752304 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06752304 currently recruiting?
Yes, NCT06752304 is actively recruiting participants. Contact the research team at martina.isaksson@uu.se for enrollment information.
Where is the NCT06752304 trial being conducted?
This trial is being conducted at Uppsala, Sweden.
Who is sponsoring the NCT06752304 clinical trial?
NCT06752304 is sponsored by Uppsala University Hospital. The trial plans to enroll 800 participants.